JNJ vs PG
Johnson & Johnson vs The Procter & Gamble Company · Updated Nov 13, 2026
JNJ — 16 winsPG — 7 wins
Price Performance
JNJ +46.63%PG +14.73%
Performance
| JNJ | PG | |
|---|---|---|
| 1 Month | +11.92% | +7.57% |
| 3 Months | +9.15% | +16.48% |
| 6 Months | +23.13% | +17.98% |
| YTD | +37.32% | +17.49% |
| 1 Year | +46.61% | +14.56% |
| 3 Year | +75.85% | +12.03% |
| 5 Year | +75.43% | +24.31% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +38.1% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| PG | +19.7% | -13.7% | +12.7% | -3.3% | -7.0% | +18.7% | +12.8% | +36.8% | +1.4% | +9.1% | +7.3% | -12.2% |
Valuation
| JNJ | PG | |
|---|---|---|
| P/E Ratio | 32.85 | 24.62 |
| Forward P/E | 11.17 | 11.86 |
| PEG Ratio | 2.75 | 4.79 |
| P/S Ratio | 7.01 | 4.48 |
| P/B Ratio | 8.31 | 7.10 |
| EV/EBITDA | 21.22 | 17.15 |
Financials
| JNJ | PG | |
|---|---|---|
| EPS (TTM) | $8.65 | $6.84 |
| Gross Margin | +71.49% | +49.51% |
| Operating Margin | +26.58% | +21.55% |
| Net Margin | +21.76% | +0.09% |
| ROE | +25.92% | +23.23% |
| ROA | +10.47% | +9.90% |
| Debt/Equity | 0.22 | 0.68 |
Growth
| JNJ | PG | |
|---|---|---|
| Revenue Growth YoY | +9.91% | +7.38% |
| Revenue Growth QoQ | -2.04% | -4.38% |
| EPS Growth YoY | -52.86% | +5.84% |
| EPS Growth QoQ | +1.90% | -8.43% |
Technical
| JNJ | PG | |
|---|---|---|
| RSI (14) | 64.54 | 69.74 |
| % From 20-Day SMA | +5.24% | +3.38% |
| % From 50-Day SMA | +6.55% | +9.48% |
| % From 200-Day SMA | +13.90% | +12.51% |
| % From 52-Week High | -0.66% | -1.26% |
| % From 52-Week Low | +47.19% | +22.35% |
Analyst Ratings
JNJ
Buy(24 analysts)
Strong SellHoldStrong Buy
Price Target
$285.31
+3.75% upside
PG
Buy(23 analysts)
Strong SellHoldStrong Buy
Price Target
$166.78
+0.74% upside
Overview
| JNJ | PG | |
|---|---|---|
| Sector | Healthcare | Consumer Defensive |
| Industry | Drug Manufacturers - General | Household & Personal Products |
| Exchange | NYSE | NYSE |
| Market Cap | $675.03B | $388.62B |
| Shares Outstanding | 2.41B | 2.32B |
| Avg Volume (10D) | 7.93M | 10.17M |
| Dividend Yield | 1.88% | 2.58% |
Frequently Asked Questions
Is JNJ or PG a better buy right now?
Based on 23 comparable metrics, JNJ leads in 16 categories while PG leads in 7. JNJ has a consensus analyst rating with 24 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or PG?
Over the past year, JNJ returned +46.61% compared to PG's +14.56%. In the short term (1 month), JNJ returned +11.92% vs PG's +7.57%.
Is JNJ or PG more expensive?
JNJ trades at a P/E of 32.85 compared to PG's 24.62. On a price-to-sales basis, JNJ trades at 7.01x vs PG's 4.48x. Forward P/E: JNJ at 11.17 vs PG at 11.86.
Which stock has higher growth, JNJ or PG?
JNJ's revenue grew +9.91% year-over-year compared to PG's +7.38%. EPS growth: JNJ at -52.86% vs PG at +5.84%.
Do JNJ and PG pay dividends?
JNJ pays a dividend with a yield of 1.88%. PG pays a dividend with a yield of 2.58%.
Which stock do analysts prefer, JNJ or PG?
JNJ has 24 analysts with a target price of $285.31 (+3.75% upside). PG has 23 analysts with a target of $166.78 (+0.74% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.